Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Anti-inflammatory function of Alzheimer's disease drugs revealed

The mechanism in anti-Alzheimer's disease drugs that inhibits the production of a destructive, inflammation-causing protein in the brain has been revealed by researchers at the Hebrew university of Jerusalem.

28 Jul 2005

1 in 166 children under age 10 are affected by autism

New statistics surrounding autism make it the number one growing developmental disability in the country. The Centers for Disease Control and Prevention estimates as many as one in 166 children under age 10 are affected by the disorder. Nearly two million people in the U.S. are living with autism.

19 Jul 2005

Scientists have begun to clarify how one of the body's molecules controls the trafficking of T cells through the blood

...lymph nodes and on to tissues to fight infection -- a crucial response that sometimes goes awry, attacking the body's own tissues and causing autoimmune diseases.

17 Jul 2005

Research explains one of the fundamental mysteries of multiple sclerosis

Scientists have pinpointed a chemical messenger that frees some white blood cells from the body's normal constraints, allowing the cells to act like renegades that could damage nerves in the central nervous system. The work, to be published in the July 15 issue of the Journal of Immunology and just published on-line, helps explain one of the fundamental mysteries of multiple sclerosis (MS).

11 Jul 2005

Tourette's and obsessive compulsive disorders linked to strep throat

A new study is suggesting that Strep throat infections can triple a child's risk of developing compulsive behaviors or tics, an indication that the same antibodies that attack the infection may also damage brain cells.

6 Jul 2005

No surprise - teens in the UK need more sunshine!

A British scientist suggests that some adolescents in Britain might not be getting enough sunlight to satisfy their body's requirement for vitamin D throughout the year.

4 Jul 2005

Researchers have identified a highly specific pathway that causes inflammation in lung tissue

...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.

30 Jun 2005

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

Oregon Health & Science University researchers have measured genetic changes reflecting a drop in the body's ability to suppress inflammatory cells that attack nerve fibers and promote progression of multiple sclerosis.

27 Jun 2005

New insight into autoimmune disease

The immune system is a complex and powerful weapon that provides protection against bacteria and viruses that, if left unchecked, would wreak havoc throughout the human body.

21 Jun 2005

Canada first country to approve cannabis based painkiller

Canada has become the first country to approve a cannabis based painkiller for multiple sclerosis (MS) patients.

21 Jun 2005

Immunomedics awarded U.S. and Australian patents

Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.

16 Jun 2005

Spinal arthritis often overlooked in children

When kids or teens experience aching joints and stiffness it may be more than growing pains. It may be arthritis of the spine and other joints (ankylosing spondylitis), which researchers report can often go undiagnosed for years and years, leading to serious problems in adulthood.

15 Jun 2005

Venom of marine cone snails may provide an improved treatment for neuropathic pain associated with diabetes

A cone snail toxin discovered by Melbourne researchers has proven to have great potential for easing pain and could provide an improved treatment for neuropathic pain associated with diabetes.

12 Jun 2005

Multiple sclerosis drug Tysabri could be back on the market later in the year

The drug Tysabri which was approved by the Food and Drug Administration (FDA) for the treatment of multiple sclerosis in November 2004, was taken off the market in late February, after two cases of progressive multifocal leukoencephalopathy, or PML, appeared in patients given the drug during clinical trials.

9 Jun 2005

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

The key to understanding our brains may lie within a one-millimeter long worm, new research from Rockefeller University indicates. Reporting in the June issue of Developmental Cell, Shai Shaham, Ph.D., and graduate student Elliot Perens use the roundworm, C. elegans, to investigate the mysterious glial cell, which makes up 90 percent of the human brain and, when it malfunctions, can contribute to diseases like Parkinson's disease and schizophrenia.

9 Jun 2005

Canada's first two human embryonic stem cell lines

A senior scientist at Mount Sinai Hospital has developed Canada's first two human embryonic stem cell lines, giving researchers across the country new potential and hope for eventually discovering treatments and cures for many chronic and fatal diseases.

8 Jun 2005

Chemicals in Cannabis may help mentally ill

Smoking cannabis which has previously been shown to damage mental health, now according to a new study may be useful in relieving the symptoms of severe mental illnesses such as bipolar disorder.

6 Jun 2005

Medical Research Council funds research to look at cannabis based medicines in multiple sclerosis treatment

A trial to determine whether cannabis-based medicines can reduce disability in patients with multiple sclerosis (MS) has been funded by the Medical Research Council (MRC).

24 May 2005

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Researchers showed that the immune system can brand foreign proteins by chemically modifying their structure, and that these modifications increased the chances that cells known as lymphocytes would recognize the trespassers and attack them.

17 May 2005

Antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system

By studying animals, Johns Hopkins researchers have discovered that the antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system, problems that can develop even though antiretroviral therapy controls the virus elsewhere in the body.

1 May 2005

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Anti-inflammatory function of Alzheimer's disease drugs revealed

1 in 166 children under age 10 are affected by autism

Scientists have begun to clarify how one of the body's molecules controls the trafficking of T cells through the blood

Research explains one of the fundamental mysteries of multiple sclerosis

Tourette's and obsessive compulsive disorders linked to strep throat

No surprise - teens in the UK need more sunshine!

Researchers have identified a highly specific pathway that causes inflammation in lung tissue

OHSU scientists say low FOXP3 means fewer disease-fighting cells, but new drug may help multiple sclerosis

New insight into autoimmune disease

Canada first country to approve cannabis based painkiller

Immunomedics awarded U.S. and Australian patents

Spinal arthritis often overlooked in children

Venom of marine cone snails may provide an improved treatment for neuropathic pain associated with diabetes

Multiple sclerosis drug Tysabri could be back on the market later in the year

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

Canada's first two human embryonic stem cell lines

Chemicals in Cannabis may help mentally ill

Medical Research Council funds research to look at cannabis based medicines in multiple sclerosis treatment

Scientists have uncovered a new method the immune system uses to label foreign invaders as targets to be attacked

Antibiotic minocycline might help alleviate HIV's negative effects on the brain and central nervous system

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in